Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma
(39:29): So on the women's side, and I think that yes, and there's still a change to be made, and I'm actually a little bit on behalf of my generation, maybe not too proud of the change we made because we didn't do a lot of change
Low non-specific binding
How to Use Phototherapy Patches (+ My Tips) If youre going to patch, I have a few tips thatll help you
Leon Barnes, MD , Professor, Department of Pathology, University of Pittsburgh Medical Center Editor(s): Peter Fritsch, MD , Chair, Professor, Department of Dermatology, University of Innsbruck, Austria Michael J Wells, MD , Staff Physician, Department of Dermatology, Texas Tech University Health Sciences Center Drore Eisen, MD, DDS , Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati Joel M Gelfand, MD, MSCE , Assistant Professor, Department of Dermatology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Hospital William D James, MD , Program Director, Vice-Chair, Albert M Kligman Professor, Department of Dermatology, University of Pennsylvania School of Medicine 2010 Update on new melanoma vaccine trials BACKGROUND: Melanoma is the most serious type of skin cancer
